Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-8-1
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0211-6995
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
234-42, 244
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16053004-Cell Division, pubmed-meshheading:16053004-Clinical Trials, Phase III as Topic, pubmed-meshheading:16053004-Double-Blind Method, pubmed-meshheading:16053004-Gastrointestinal Diseases, pubmed-meshheading:16053004-Graft Rejection, pubmed-meshheading:16053004-Hematologic Diseases, pubmed-meshheading:16053004-Humans, pubmed-meshheading:16053004-IMP Dehydrogenase, pubmed-meshheading:16053004-Immunosuppressive Agents, pubmed-meshheading:16053004-Incidence, pubmed-meshheading:16053004-Kidney Transplantation, pubmed-meshheading:16053004-Lymphocytes, pubmed-meshheading:16053004-Multicenter Studies as Topic, pubmed-meshheading:16053004-Mycophenolic Acid, pubmed-meshheading:16053004-Nucleotides, pubmed-meshheading:16053004-Randomized Controlled Trials as Topic, pubmed-meshheading:16053004-Tablets, Enteric-Coated
pubmed:year
2005
pubmed:articleTitle
[Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
pubmed:affiliation
Servicio de Nefrología, Hospital Clínico San Carlos, Madrid. sanchezfruct@telefonica.net
pubmed:publicationType
Journal Article, Comparative Study